Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-25

FDA Approved: CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental ANDA for a generic chlordiazepoxide and amitriptyline hydrochloride tablet by Mylan Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE

Snippet

SUPPL AP for CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE (CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE)